{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:08:18Z","timestamp":1791148098379,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2002,1]]},"DOI":"10.1378\/chest.121.1.55","type":"journal-article","created":{"date-parts":[[2003,6,13]],"date-time":"2003-06-13T20:09:19Z","timestamp":1055534959000},"page":"55-63","source":"Crossref","is-referenced-by-count":137,"title":["Long-term Benefits of Inhaled Tobramycin in Adolescent Patients With Cystic Fibrosis"],"prefix":"10.1016","volume":"121","author":[{"given":"Richard B.","family":"Moss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1378\/chest.121.1.55_bib1","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1126\/science.1375392","article-title":"Cystic fibrosis: molecular biology and therapeutic implications","volume":"256","author":"Collins","year":"1992","journal-title":"Science"},{"key":"10.1378\/chest.121.1.55_bib2","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1164\/ajrccm.154.5.8912731","article-title":"Cystic fibrosis","volume":"154","author":"Davis","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.121.1.55_bib3","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/clinids\/21.4.839","article-title":"Cystic fibrosis: pathogenesis, pulmonary infection, and treatment","volume":"21","author":"Moss","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1378\/chest.121.1.55_bib4","series-title":"Patient registry 1998 annual data report","author":"Cystic Fibrosis Foundation","year":"1999"},{"key":"10.1378\/chest.121.1.55_bib5","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1056\/NEJM199204303261804","article-title":"Prediction of mortality in patients with cystic fibrosis","volume":"326","author":"Kerem","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.121.1.55_bib6","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1056\/NEJM199306173282403","article-title":"Efficacy of aerosolized tobramycin in patients with cystic fibrosis","volume":"328","author":"Ramsey","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.121.1.55_bib7","series-title":"Patient registry 1996 annual data report","author":"Cystic Fibrosis Foundation","year":"1997"},{"key":"10.1378\/chest.121.1.55_bib8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/ppul.1950190103","article-title":"Effects of Pseudomonas aeruginosa colonization on lung function and anthropometric variables in children with cystic fibrosis","volume":"19","author":"Pamukcu","year":"1995","journal-title":"Pediatr Pulmonol"},{"key":"10.1378\/chest.121.1.55_bib9","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/ppul.1950120306","article-title":"Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis","volume":"12","author":"Henry","year":"1992","journal-title":"Pediatr Pulmonol"},{"key":"10.1378\/chest.121.1.55_bib10","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0022-3476(97)70025-8","article-title":"Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis","volume":"131","author":"Corey","year":"1997","journal-title":"J Pediatr"},{"key":"10.1378\/chest.121.1.55_bib11","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1651-2227.1983.tb09789.x","article-title":"Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection","volume":"72","author":"Szaff","year":"1983","journal-title":"Acta Paediatr Scand"},{"key":"10.1378\/chest.121.1.55_bib12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJM199901073400104","article-title":"Intermittent administration of inhaled tobramycin in patients with cystic fibrosis","volume":"340","author":"Ramsey","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.121.1.55_bib13","first-page":"725","article-title":"Changes in the normal maximal expiratory flow-volume curve with growth and aging","volume":"127","author":"Knudson","year":"1983","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.121.1.55_bib14","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1086\/314727","article-title":"Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis","volume":"179","author":"Burns","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1378\/chest.121.1.55_bib15","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0895-4356(88)90063-7","article-title":"A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto","volume":"41","author":"Corey","year":"1988","journal-title":"J Clin Epidemiol"},{"key":"10.1378\/chest.121.1.55_bib16","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0261-5614(98)80061-7","article-title":"Nutrition in adults with cystic fibrosis","volume":"17","author":"Bell","year":"1998","journal-title":"Clin Nutr"},{"key":"10.1378\/chest.121.1.55_bib17","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/oxfordjournals.aje.a008664","article-title":"Determinants of mortality from cystic fibrosis in Canada, 1970\u20131989","volume":"143","author":"Corey","year":"1996","journal-title":"Am J Epidemiol"},{"key":"10.1378\/chest.121.1.55_bib18","first-page":"130","article-title":"Nutritional state and lung disease in cystic fibrosis","volume":"41","author":"Bakker","year":"1992","journal-title":"Neth J Med"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215346419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215346419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T16:54:57Z","timestamp":1553100897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215346419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["S0012369215346419"],"URL":"https:\/\/doi.org\/10.1378\/chest.121.1.55","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2002,1]]}}}